Cruz JM - Search Results

1

Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study.

Muss HB, Case LD, Atkins JN, Bearden JD 3rd, Cooper MR, Cruz JM, Jackson DV Jr, O'Rourke MA, Pavy MD, Powell BL, et al. Muss HB, et al. Among authors: cruz jm. J Clin Oncol. 1994 Aug;12(8):1630-8. doi: 10.1200/JCO.1994.12.8.1630. J Clin Oncol. 1994. PMID: 8040675 Clinical Trial.

2

High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.

Muss HB, Case LD, Capizzi RL, Cooper MR, Cruz J, Jackson D, Richards F 2nd, Powell BL, Spurr CL, White D, et al. Muss HB, et al. J Clin Oncol. 1990 Nov;8(11):1797-805. doi: 10.1200/JCO.1990.8.11.1797. J Clin Oncol. 1990. PMID: 2230868 Clinical Trial.

3

Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.

Richards F 2nd, Case LD, White DR, Muss HB, Spurr CL, Jackson DV, Cooper MR, Zekan P, Cruz J, Stuart JJ, et al. Richards F 2nd, et al. J Clin Oncol. 1986 Apr;4(4):565-70. doi: 10.1200/JCO.1986.4.4.565. J Clin Oncol. 1986. PMID: 3514806 Clinical Trial.

4

High-dose progestin therapy for metastatic breast cancer.

Muss HB, Cruz JM. Muss HB, et al. Among authors: cruz jm. Ann Oncol. 1992 Aug;3 Suppl 3:15-20. doi: 10.1093/annonc/3.suppl_3.s15. Ann Oncol. 1992. PMID: 1390312 Review.

5

High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer.

Cruz JM, Muss HB, Russell G. Cruz JM, et al. Oncology. 1992;49 Suppl 2:8-11. doi: 10.1159/000227119. Oncology. 1992. PMID: 1461630 Clinical Trial.

6

Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association.

Muss HB, Case LD, Richards F 2nd, White DR, Cooper MR, Cruz JM, Powell BL, Spurr CL, Capizzi RL. Muss HB, et al. Among authors: cruz jm. N Engl J Med. 1991 Nov 7;325(19):1342-8. doi: 10.1056/NEJM199111073251904. N Engl J Med. 1991. PMID: 1922236 Free article. Clinical Trial.

7

Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy.

Cruz JM, Muss HB, Brockschmidt JK, Evans GW. Cruz JM, et al. Semin Oncol. 1990 Dec;17(6 Suppl 9):63-7. Semin Oncol. 1990. PMID: 2259928 Clinical Trial.

8

Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.

Muss HB, Wells HB, Paschold EH, Black WR, Cooper MR, Capizzi RL, Christian R, Cruz JM, Jackson DV, Powell BL, et al. Muss HB, et al. Among authors: cruz jm. J Clin Oncol. 1988 Jul;6(7):1098-106. doi: 10.1200/JCO.1988.6.7.1098. J Clin Oncol. 1988. PMID: 3292710 Clinical Trial.

9

Menogaril in the treatment of relapsed multiple myeloma. A phase II trial of the Cancer Center of Wake Forest University.

Cruz JM, Case LD, Dalton HB, Ramseur WL, Richards F 2nd, Jackson DV, Muss HB, Zekan PJ, Brodkin RA, Brown RC, et al. Cruz JM, et al. Invest New Drugs. 1992 Apr;10(1):35-7. doi: 10.1007/BF01275478. Invest New Drugs. 1992. PMID: 1535064 Clinical Trial.

10

A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma.

Muss HB, Spell N, Scudiery D, Capizzi RL, Cooper MR, Cruz J, Jackson DV, Richards F 2nd, Spurr CL, White DR, et al. Muss HB, et al. Invest New Drugs. 1990 Feb;8(1):125-30. doi: 10.1007/BF00216938. Invest New Drugs. 1990. PMID: 2345067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters